- Home
- TRUG vs CERO Comparison
TRUG vs CERO Comparison
Compare TRUG & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- CERO
- Stock Information
- Founded
- TRUG 1983
- CERO 2017
- Country
- TRUG United States
- CERO United States
- Employees
- TRUG N/A
- CERO N/A
- Industry
- TRUG
- CERO
- Sector
- TRUG
- CERO
- Exchange
- TRUG NYSE
- CERO Nasdaq
- Market Cap
- TRUG 7.4M
- CERO 8.5M
- IPO Year
- TRUG N/A
- CERO N/A
- Fundamental
- Price
- TRUG $0.37
- CERO $0.06
- Analyst Decision
- TRUG
- CERO
- Analyst Count
- TRUG 0
- CERO 0
- Target Price
- TRUG N/A
- CERO N/A
- AVG Volume (30 Days)
- TRUG 11.5M
- CERO 33.3M
- Earning Date
- TRUG 02-12-2025
- CERO 11-19-2024
- Dividend Yield
- TRUG N/A
- CERO N/A
- EPS Growth
- TRUG N/A
- CERO N/A
- EPS
- TRUG N/A
- CERO N/A
- Revenue
- TRUG $21,917,131.00
- CERO N/A
- Revenue This Year
- TRUG N/A
- CERO N/A
- Revenue Next Year
- TRUG N/A
- CERO N/A
- P/E Ratio
- TRUG N/A
- CERO N/A
- Revenue Growth
- TRUG 7.68
- CERO N/A
- 52 Week Low
- TRUG $0.35
- CERO $0.05
- 52 Week High
- TRUG $11.82
- CERO $12.80
- Technical
- Relative Strength Index (RSI)
- TRUG 39.73
- CERO 39.14
- Support Level
- TRUG $0.42
- CERO $0.05
- Resistance Level
- TRUG $0.92
- CERO $0.21
- Average True Range (ATR)
- TRUG 0.11
- CERO 0.02
- MACD
- TRUG 0.00
- CERO -0.01
- Stochastic Oscillator
- TRUG 3.98
- CERO 14.60
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.